A Business at a Glance
0 of 1 daily views used (1 remaining). Sign up free for +5 more daily views (6 total), or try AAPL for a full preview.
ESCALON MEDICAL CORP
ESMC
$1M
Mkt Cap
$0.20
+0.00%
ESCALON MEDICAL CORP (ESMC) has a 5-year average return on invested capital (ROIC) of 6.3%. This is below average and may indicate limited pricing power.
ESCALON MEDICAL CORP (ESMC) has a market capitalization of $1M. It is classified as a small-cap stock.
ESCALON MEDICAL CORP (ESMC) does not currently pay a regular dividend.
ESCALON MEDICAL CORP (ESMC) operates in the Electromedical & Electrotherapeutic Apparatus industry, within the Healthcare sector.
ESCALON MEDICAL CORP (ESMC) reported annual revenue of $12 million in its most recent fiscal year, based on SEC EDGAR filings.
ESCALON MEDICAL CORP (ESMC) has a net profit margin of 0.9%. This is a modest margin.
ESCALON MEDICAL CORP (ESMC) generated $377 thousand in free cash flow in its most recent fiscal year. Positive free cash flow supports dividends, buybacks, and debt reduction.
Company Overview Escalon Medical Corp. ("Escalon" or "Company") is a Pennsylvania corporation initially incorporated in California in 1987, and reincorporated in Pennsylvania in November 2001. Within this document, the “Company” collectively shall mean Escalon, which includes its division called "Trek" and its wholly owned subsidiaries: Sonomed, Inc. (“Sonomed”), Escalon Digital Solutions, Inc. (“EMI”), and Sonomed IP Holdings, Inc. All intercompany accounts and transactions have been eliminated. The Company operates in the healthcare market, specializing in the development, manufacture, marketing and distribution of medical devices for ophthalmic applications. The Company and its products are subject to regulation and inspection by the United States Food and Drug Administration (the “FDA”).
| Metric | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|---|
| Revenue | 12M | 12M | 12M | 12M | 11M | 10M |
| Net Income | -239K | 106K | -177K | 222K | -34K | -103K |
| EPS | $-0.03 | $0.00 | $-0.02 | $0.03 | $-0.00 | $-0.01 |
| Free Cash Flow | -394K | 377K | -643K | 318K | -1.0M | 829K |
| ROIC | -10.1% | 11.0% | -4.7% | 53.2% | -27.7% | -0.5% |
| Gross Margin | - | 45.7% | 43.0% | 45.0% | 43.0% | 42.3% |
| Debt/Equity | 0.07 | 0.20 | 0.21 | 0.38 | 0.71 | 1.11 |
| Dividends/Share | $0.00 | - | - | - | - | - |
| Operating Income | -200K | 133K | -104K | 479K | -470K | -34K |
| Operating Margin | -1.6% | 1.1% | -0.9% | 3.9% | -4.4% | -0.3% |
| ROE | -13.5% | 5.7% | -9.8% | 11.4% | -2.3% | -7.1% |
| Shares Outstanding | 7M | 7M | 9M | 7M | 7M | 10M |
| Metric | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||||
| Revenue | 12M | 13M | 12M | 11M | 11M | 9.6M | 9.4M | 10M | 11M | 12M | 12M | 12M | 12M |
| Gross Margin | 49.1% | 46.7% | 46.5% | 45.9% | 44.8% | 48.1% | 44.7% | 42.3% | 43.0% | 45.0% | 43.0% | 45.7% | N/A |
| R&D | 1.3M | 1.3M | 1.5M | 1.1M | 500K | 740K | 1.1M | 890K | 991K | 819K | 688K | 753K | 804K |
| SG&A | 5.1M | 5.9M | 5.1M | 4.6M | 4.4M | 4.1M | 3.9M | 3.6M | 4.1M | 4.2M | 4.6M | 4.6M | 4.8M |
| EBIT | -358K | -1.1M | -1.1M | -627K | 205K | -253K | -1.4M | -34K | -470K | 479K | -104K | 133K | -200K |
| Op. Margin | -2.9% | -8.0% | -9.9% | -5.6% | 1.8% | -2.6% | -14.9% | -0.3% | -4.4% | 3.9% | -0.9% | 1.1% | -1.6% |
| Net Income | -382K | -541K | -1.2M | -727K | 564K | -302K | -702K | -103K | -34K | 222K | -177K | 106K | -239K |
| Net Margin | -3.1% | -4.1% | -9.9% | -6.5% | 4.9% | -3.1% | -7.5% | -1.0% | -0.3% | 1.8% | -1.5% | 0.9% | -1.9% |
| Non-Recurring | 0 | 0 | 0 | 125K | 500K | 0 | 0 | 605K | 0 | 150K | 0 | 0 | 0 |
| Returns on Capital | |||||||||||||
| ROIC | -8.2% | -27.8% | -65.6% | -55.7% | 10.7% | -15.6% | -124.6% | -0.5% | -27.7% | 53.2% | -4.7% | 11.0% | -10.1% |
| ROE | -10.5% | -16.8% | -47.0% | -47.0% | 31.4% | -13.2% | -38.2% | -7.1% | -2.3% | 11.4% | -9.8% | 5.7% | -13.5% |
| ROA | -5.1% | -7.6% | -19.1% | -13.8% | 10.8% | -5.7% | -12.9% | -1.8% | -0.6% | 4.2% | -3.7% | 2.2% | -4.8% |
| Cash Flow | |||||||||||||
| Op. Cash Flow | -623K | -457K | -1.2M | -506K | 107K | -473K | -168K | 839K | -1.0M | 325K | -603K | 381K | -386K |
| Free Cash Flow | -645K | -493K | -1.3M | -506K | 77K | -495K | -228K | 829K | -1.0M | 318K | -643K | 377K | -394K |
| Owner Earnings | -652K | -538K | -1.3M | -552K | 58K | -523K | -219K | 794K | -1.1M | 280K | -649K | 343K | -420K |
| CapEx | 23K | 36K | 57K | 0 | 29K | 22K | 60K | 9K | 0 | 7K | 40K | 4K | 8K |
| Maint. CapEx | 13K | 14K | 25K | 46K | 49K | 50K | 50K | 45K | 48K | 45K | 46K | 38K | 34K |
| Growth CapEx | 10K | 22K | 32K | N/A | 0 | 0 | 10K | 0 | N/A | 0 | 0 | 0 | 0 |
| D&A | 13K | 14K | 25K | 46K | 49K | 50K | 50K | 45K | 48K | 45K | 46K | 38K | 34K |
| CapEx/OCF | N/A | N/A | N/A | N/A | N/A | N/A | N/A | 1.1% | N/A | 2.1% | N/A | 1.0% | 0.0% |
| Capital Allocation | |||||||||||||
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividend Yield | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Share Buybacks | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Buyback Yield | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | 0.0% |
| Stock-Based Comp | 17K | 67K | 52K | 0 | 0 | 0 | 0 | N/A | N/A | N/A | N/A | N/A | N/A |
| Debt Repayment | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3K | 3K | 4K | 3K | 3K |
| Balance Sheet | |||||||||||||
| Net Debt | N/A | N/A | -538K | -294K | -498K | -880K | -624K | -1.7M | -136K | -1.0M | -36K | -707K | -208K |
| Cash & Equiv. | 2.0M | 1.5M | 538K | 544K | 663K | 1.1M | 826K | 1.7M | 594K | 890K | 209K | 546K | 337K |
| Long-Term Debt | N/A | N/A | N/A | N/A | N/A | N/A | N/A | 8K | 4K | 160K | 129K | 86K | 126K |
| Debt/Equity | 1.21 | 1.19 | 0.00 | 0.21 | 0.07 | 0.09 | 0.13 | 1.11 | 0.71 | 0.38 | 0.21 | 0.20 | 0.07 |
| Interest Coverage | N/A | N/A | -100.0 | -6.2 | 1.6 | -14.6 | -103.1 | -1.5 | -25.5 | 22.0 | -5.0 | 5.9 | 5.9 |
| Equity | 3.5M | 3.0M | 1.9M | 1.2M | 2.4M | 2.2M | 1.5M | 1.5M | 1.5M | 1.9M | 1.8M | 1.9M | 1.8M |
| Total Assets | 7.7M | 6.5M | 5.5M | 5.0M | 5.4M | 5.1M | 5.7M | 5.7M | 5.2M | 5.3M | 4.8M | 5.0M | 5.0M |
| Total Liabilities | 4.2M | 3.6M | 3.6M | 3.8M | 3.0M | 3.0M | 4.2M | 4.2M | 3.7M | 3.4M | 2.9M | 3.1M | 3.2M |
| Intangibles | 5K | 3K | 2K | 0 | 161K | 142K | 122K | 102K | 83K | 70K | 49K | 30K | 20K |
| Retained Earnings | -66M | -67M | -68M | -69M | -68M | -68M | -69M | -69M | -69M | -68M | -69M | -68M | -69M |
| Working Capital | 3.5M | 3.0M | 1.8M | 1.2M | 2.3M | 2.0M | 1.5M | 1.2M | 1.2M | 1.8M | 1.7M | 1.9M | 1.7M |
| Current Assets | 6.9M | 5.8M | 4.5M | 4.2M | 4.6M | 4.3M | 4.3M | 4.6M | 4.2M | 4.6M | 4.4M | 4.6M | 4.3M |
| Current Liabilities | 3.4M | 2.8M | 2.8M | 3.0M | 2.2M | 2.3M | 2.9M | 3.4M | 3.0M | 2.9M | 2.7M | 2.7M | 2.6M |
| Per Share Data | |||||||||||||
| EPS | -0.05 | -0.07 | -0.15 | -0.10 | 0.06 | -0.04 | -0.09 | -0.01 | -0.00 | 0.03 | -0.02 | 0.00 | -0.03 |
| Owner EPS | -0.09 | -0.07 | -0.17 | -0.08 | 0.01 | -0.07 | -0.03 | 0.08 | -0.15 | 0.04 | -0.07 | 0.05 | -0.06 |
| Book Value | 0.45 | 0.39 | 0.25 | 0.16 | 0.26 | 0.29 | 0.19 | 0.14 | 0.20 | 0.26 | 0.20 | 0.26 | 0.24 |
| Cash Flow/Share | -0.08 | -0.06 | -0.16 | -0.07 | 0.01 | -0.06 | -0.02 | 0.08 | -0.14 | 0.04 | -0.07 | 0.05 | -0.03 |
| Dividends/Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | 0.00 |
| Shares Out. | 7.6M | 7.7M | 7.7M | 7.3M | 9.4M | 7.5M | 7.8M | 10.3M | 7.4M | 7.4M | 8.8M | 7.4M | 7.4M |
| Valuation | |||||||||||||
| P/E Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | 8.3 | N/A | N/A | -6.2 |
| P/FCF | N/A | N/A | N/A | N/A | 26.7 | N/A | N/A | 3.4 | N/A | 5.8 | N/A | 6.9 | N/A |
| EV/EBIT | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | 0.6 | N/A | 12.3 | N/A |
| Price/Book | N/A | N/A | N/A | N/A | N/A | N/A | N/A | 1.9 | 0.5 | 1.0 | 0.7 | 1.4 | 0.8 |
| Price/Sales | 2.2 | 0.9 | 0.7 | 0.2 | N/A | 0.1 | 0.1 | 0.2 | 0.1 | 0.1 | 0.2 | 0.1 | 0.1 |
| FCF Yield | -4.8% | -4.5% | -20.9% | -38.7% | N/A | -54.7% | -19.5% | 29.7% | -141.6% | 17.3% | -51.9% | 14.5% | -26.6% |
| Market Cap | 13M | 11M | 6.0M | 1.3M | N/A | 905K | 1.2M | 2.8M | 742K | 1.8M | 1.2M | 2.6M | 1.5M |
| Avg. Price | 1.56 | 1.49 | 1.03 | 0.34 | 0.19 | 0.17 | 0.14 | 0.20 | 0.14 | 0.10 | 0.23 | 0.18 | 0.20 |
| Year-End Price | 1.75 | 1.42 | 0.78 | 0.18 | 0.22 | 0.12 | 0.15 | 0.27 | 0.10 | 0.25 | 0.14 | 0.35 | 0.20 |
ESCALON MEDICAL CORP passes 3 of 9 quality checks, indicating weak fundamentals.
The company's 5-year average ROIC is 6.3% with a gross margin of 43.8%. At current prices, the estimated annualized return to fair value is -6.2%.
ESCALON MEDICAL CORP (ESMC) has a debt-to-equity ratio of 0.20. This indicates a conservatively financed balance sheet.
ESCALON MEDICAL CORP (ESMC) has a return on equity (ROE) of 5.7%. This indicates moderate shareholder returns.
ESCALON MEDICAL CORP (ESMC) has a 5-year average gross margin of 43.8%. This indicates decent pricing power.
The Ledger Terminal provides 15 years of financial data for ESCALON MEDICAL CORP (ESMC), sourced directly from SEC EDGAR filings. This includes income statements, balance sheets, cash flow statements, and key financial ratios.
ESCALON MEDICAL CORP (ESMC) has a book value per share of $0.26, based on its most recent annual SEC filing.
No recent press releases.